Advertisement
Canada markets open in 8 hours 17 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7325
    +0.0002 (+0.02%)
     
  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     
  • Bitcoin CAD

    87,589.21
    -14.09 (-0.02%)
     
  • CMC Crypto 200

    1,386.66
    +4.09 (+0.30%)
     
  • GOLD FUTURES

    2,348.20
    +5.70 (+0.24%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,759.25
    +191.75 (+1.09%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    38,064.16
    +435.68 (+1.16%)
     
  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Arena Pharmaceuticals (ARNA) in Focus: Stock Slumps 9.4%


Arena Pharmaceuticals, Inc. (ARNA) saw a big move last session, as the company’s shares fell by over 9% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend for ARNA, as the stock is now down nearly 19% since Jun 13.

This biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. However, the consensus for loss estimate has widened over the past month. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

ARNA currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Medical and Biomedical industry include ANI Agenus Inc. (AGEN), Biogen Idec Inc. (BIIB) and Oncolytics Biotech Inc. (ONCY). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





ARENA PHARMACEUTICALS INC (ARNA): Free Stock Analysis Report


Zacks Investment Research